doi: 10.1016/j.bmcl.2006.03.030.
Epub 2006 Mar 31.
Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development
Affiliations
- PMID: 16580202
- DOI: 10.1016/j.bmcl.2006.03.030
Item in Clipboard
Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development
Bioorg Med Chem Lett.
.
Abstract
Small molecule antagonists of the vanilloid receptor TRPV1 (also known as VR1) are disclosed. Pyrrolidinyl ureas such as 8 and 15 (SB-705498) emerged as lead compounds following optimisation of the previously described urea SB-452533. Pharmacological studies using electrophysiological and FLIPR-Ca2+-based assays showed that compounds such as 8 and 15 were potent antagonists versus the multiple chemical and physical modes of TRPV1 activation (namely capsaicin, acid and noxious heat). Furthermore, 15 possessed suitable developability properties to enable progression of this compound into in vivo studies and subsequently clinical development.
Similar articles
-
Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.J Pharmacol Exp Ther. 2007 Jun;321(3):1183-92. doi: 10.1124/jpet.106.116657. Epub 2007 Mar 28. J Pharmacol Exp Ther. 2007. PMID: 17392405
-
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.Pain. 2007 Nov;132(1-2):132-41. doi: 10.1016/j.pain.2007.06.006. Epub 2007 Jul 30. Pain. 2007. PMID: 17659837 Clinical Trial.
-
(R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.J Pharmacol Exp Ther. 2008 Sep;326(3):879-88. doi: 10.1124/jpet.108.138511. Epub 2008 May 30. J Pharmacol Exp Ther. 2008. PMID: 18515644
-
TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1.Chem Soc Rev. 2008 Aug;37(8):1530-45. doi: 10.1039/b610226n. Epub 2008 Jun 20. Chem Soc Rev. 2008. PMID: 18648679 Review.
-
Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.Drug Discov Today. 2009 Jan;14(1-2):56-67. doi: 10.1016/j.drudis.2008.11.005. Epub 2008 Dec 26. Drug Discov Today. 2009. PMID: 19063991 Review.
Cited by
-
Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist.Br J Clin Pharmacol. 2014 May;77(5):777-88. doi: 10.1111/bcp.12219. Br J Clin Pharmacol. 2014. PMID: 23909699 Free PMC article. Clinical Trial.
-
Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.Br J Pharmacol. 2013 Jun;169(3):580-9. doi: 10.1111/bph.12145. Br J Pharmacol. 2013. PMID: 23441756 Free PMC article.
-
Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions.J Cell Sci. 2018 Jul 26;131(14):jcs215939. doi: 10.1242/jcs.215939. J Cell Sci. 2018. PMID: 29930087 Free PMC article.
-
Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications.Front Mol Neurosci. 2023 Aug 17;16:1239599. doi: 10.3389/fnmol.2023.1239599. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37664239 Free PMC article. Review.
-
TRPV1 in Pain and Itch.Adv Exp Med Biol. 2021;1349:249-273. doi: 10.1007/978-981-16-4254-8_12. Adv Exp Med Biol. 2021. PMID: 35138618
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous
